Delivery Order SPE2DB22D3501-SPE2DB25FWN03
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a ceiling value of $3,365.52 under a firm fixed price contract. This is a non-set-aside competitive award, with the place of performance located at the vendor's corporate office in Conshohocken, Pennsylvania, and an ultimate completion date of August 1, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $1,701.70. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by July 30, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,729.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $2,856.36 and an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on May 30, 2025, with a ceiling value of $5,701.69 and ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of emergency medical supplies critical to military healthcare operations. The contract was executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWN03Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $3,102.72 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with a completion date of July 23, 2025. The award is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, continues to serve as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's demonstrated capability to fulfill diverse federal medical supply requirements through open competition, coupled with its substantial prime indefinite delivery contract with DLA, positions it as a key supplier for military and veteran healthcare systems. This specific delivery order for epinephrine auto-injectors fulfills immediate medical supply needs within the broader context of the DLA's pharmaceutical prime vendor program supporting defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/22/25 |